AstraZeneca PLC Stock

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. 11:35:07 2024-06-14 EDT 5-day change 1st Jan Change
12,510 GBX +0.95% Intraday chart for AstraZeneca PLC -0.37% +18.02%
Sales 2024 * 51.68B 70.99B Sales 2025 * 55.58B 76.33B Capitalization 246B 338B
Net income 2024 * 8.79B 12.07B Net income 2025 * 10.45B 14.35B EV / Sales 2024 * 5.16 x
Net Debt 2024 * 20.62B 28.32B Net Debt 2025 * 14.04B 19.29B EV / Sales 2025 * 4.68 x
P/E ratio 2024 *
27.9 x
P/E ratio 2025 *
23.7 x
Employees 89,900
Yield 2024 *
1.94%
Yield 2025 *
2.04%
Free-Float 96.64%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on AstraZeneca PLC

1 day+0.95%
1 week-0.37%
Current month+2.63%
1 month+2.78%
3 months+21.53%
6 months+22.82%
Current year+18.02%
More quotes
1 week
12 300.00
Extreme 12300
12 696.00
1 month
11 858.00
Extreme 11858
12 704.00
Current year
9 461.00
Extreme 9461
12 704.00
1 year
9 461.00
Extreme 9461
12 704.00
3 years
8 029.00
Extreme 8029
12 704.00
5 years
5 871.00
Extreme 5871
12 704.00
10 years
3 680.00
Extreme 3680
12 704.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 12-09-30
Director of Finance/CFO 50 21-07-31
Chief Tech/Sci/R&D Officer - 23-07-31
Members of the board TitleAgeSince
Director/Board Member 65 17-09-30
Director/Board Member 63 17-04-26
Director/Board Member 68 99-03-31
More insiders
Date Price Change Volume
24-06-14 12,510 +0.95% 853,710
24-06-13 12,392 -0.59% 2,266,845
24-06-12 12,466 +0.73% 3,288,084
24-06-11 12,376 -1.78% 1,720,593
24-06-10 12,600 +0.35% 1,555,932

Delayed Quote London S.E., June 14, 2024 at 11:35 am

More quotes
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
158.6 USD
Average target price
174.4 USD
Spread / Average Target
+9.95%
Consensus